What is TG Therapeutics's other non-current assets?

TG Therapeutics (TGTX) reported other non-current assets of $2.02M in Q1 2026.

How has TG Therapeutics's other non-current assets changed year-over-year?

TG Therapeutics's other non-current assets decreased by 1.3% year-over-year, from $2.04M to $2.02M.

What is the long-term trend for TG Therapeutics's other non-current assets?

Over 2 years (2023 to 2025), TG Therapeutics's other non-current assets has grown at a -5.9% compound annual growth rate (CAGR), from $2.31M to $2.04M.

TG Therapeutics TGTX Other Non-Current Assets

Other Non-Current Assets at other companies

BiogenBIIB

——

BridgeBio PharmaBBIO

——

Krystal Biotech, Inc.KRYS

——

Arrowhead ResearchARWR

——

Roivant SciencesROIV

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's other non-current assets?: TG Therapeutics (TGTX) reported other non-current assets of $2.02M in Q1 2026.
How has TG Therapeutics's other non-current assets changed year-over-year?: TG Therapeutics's other non-current assets decreased by 1.3% year-over-year, from $2.04M to $2.02M.
What is the long-term trend for TG Therapeutics's other non-current assets?: Over 2 years (2023 to 2025), TG Therapeutics's other non-current assets has grown at a -5.9% compound annual growth rate (CAGR), from $2.31M to $2.04M.